Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
International Journal of Molecular Sciences · 02.07.2023 · 24 (13) · 11004
DOI: 10.3390/ijms241311004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.07.2023. Verfasst von Mengjie Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Microbiota. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the NSFC-Joint Foundation of Yunnan Province, the Guangdong Province Key Area R&D Program of China, Guangdong Province Key Area R&D Program of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a complex multifactorial chronic inflammatory disease, that includes Crohn’s disease (CD) and ulcerative colitis (UC), having progressively increasing global incidence. Disturbed intestinal flora has been highlighted as an important feature of IBD and offers promising strategies for IBD remedies. A brief overview of the variations occurring in intestinal flora during IBD is presented, and the role of the gut microbiota in intestinal barrier maintenance, immune and metabolic regulation, and the absorption and supply of nutrients is reviewed. More importantly, we review drug research on gut microbiota in the past ten years, including research on clinical and natural drugs, as well as adjuvant therapies, such as Fecal Microbiota Transplantation and probiotic supplements. We also summarize the interventions and mechanisms of these drugs on gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
ORCID-Profile: Yijie Song, Yu Xu
Förderung
- the NSFC-Joint Foundation of Yunnan Province
- the Guangdong Province Key Area R&D Program of China
- Guangdong Province Key Area R&D Program of China
- NSFC-Joint Foundation of Yunnan Province
Zitieren
APA
Zhu, M., Song, Y., Xu, Y., & Xu, H. (2023). Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. International Journal of Molecular Sciences, 24(13), 11004. https://doi.org/10.3390/ijms241311004
Vancouver
Zhu M, Song Y, Xu Y, Xu H. Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. International Journal of Molecular Sciences. 2023;24(13):11004. doi:10.3390/ijms241311004
BibTeX
@article{Zhu2023,
author = {Zhu, Mengjie and Song, Yijie and Xu, Yu and Xu, Hongxi},
title = {Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {11004},
doi = {10.3390/ijms241311004}
}
EUVIMED